Product Code: ETC070007 | Publication Date: Jul 2023 | Updated Date: Jan 2024 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
The Indonesia contract cell and gene therapy manufacturing market is expected to grow at a significant rate in the future. The demand for cell therapies among patients with cancer, autoimmune diseases, genetic disorders, as well as infectious diseases such as HIV/AIDS has increased significantly in recent years. Increasing research activities related to the development of novel therapeutics are driving the growth of this market. Moreover, growing public investments towards research and development of new therapies drives the adoption of these products in Indonesia. In addition, government initiatives to promote investment in biotechnology industry are likely to propel market growth over the forecast period.
Some significant market drivers are the growing prevalence of chronic diseases across developed countries, rising number of clinical trials conducted on advanced treatments in developing countries, increasing funding from private & public sectors for R&D activities , and rapid advancements in field of stem cells technology.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Indonesia Contract Cell and Gene Therapy Manufacturing Market Overview |
3.1 Indonesia Country Macro Economic Indicators |
3.2 Indonesia Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, 2020 & 2027F |
3.3 Indonesia Contract Cell and Gene Therapy Manufacturing Market - Industry Life Cycle |
3.4 Indonesia Contract Cell and Gene Therapy Manufacturing Market - Porter's Five Forces |
3.5 Indonesia Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume Share, By Vector, 2020 & 2027F |
3.6 Indonesia Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume Share, By Indication, 2020 & 2027F |
4 Indonesia Contract Cell and Gene Therapy Manufacturing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Indonesia Contract Cell and Gene Therapy Manufacturing Market Trends |
6 Indonesia Contract Cell and Gene Therapy Manufacturing Market, By Types |
6.1 Indonesia Contract Cell and Gene Therapy Manufacturing Market, By Vector |
6.1.1 Overview and Analysis |
6.1.2 Indonesia Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Vector, 2018 - 2027F |
6.1.3 Indonesia Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Viral Vector, 2018 - 2027F |
6.1.4 Indonesia Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Non-viral Vector, 2018 - 2027F |
6.2 Indonesia Contract Cell and Gene Therapy Manufacturing Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Indonesia Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Cancer, 2018 - 2027F |
6.2.3 Indonesia Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Neurological Diseases, 2018 - 2027F |
6.2.4 Indonesia Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Hepatological Diseases, 2018 - 2027F |
6.2.5 Indonesia Contract Cell and Gene Therapy Manufacturing Market Revenues & Volume, By Others, 2018 - 2027F |
7 Indonesia Contract Cell and Gene Therapy Manufacturing Market Import-Export Trade Statistics |
7.1 Indonesia Contract Cell and Gene Therapy Manufacturing Market Export to Major Countries |
7.2 Indonesia Contract Cell and Gene Therapy Manufacturing Market Imports from Major Countries |
8 Indonesia Contract Cell and Gene Therapy Manufacturing Market Key Performance Indicators |
9 Indonesia Contract Cell and Gene Therapy Manufacturing Market - Opportunity Assessment |
9.1 Indonesia Contract Cell and Gene Therapy Manufacturing Market Opportunity Assessment, By Vector, 2020 & 2027F |
9.2 Indonesia Contract Cell and Gene Therapy Manufacturing Market Opportunity Assessment, By Indication, 2020 & 2027F |
10 Indonesia Contract Cell and Gene Therapy Manufacturing Market - Competitive Landscape |
10.1 Indonesia Contract Cell and Gene Therapy Manufacturing Market Revenue Share, By Companies, 2020 |
10.2 Indonesia Contract Cell and Gene Therapy Manufacturing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |